What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?

Suppr

超能文献

作者信息

Lamoth Frédéric, Manuel Oriol, Venetz Jean-Pierre, Faouzi Mohamed, Meylan Pascal, Pascual Manuel

出版信息

Transplantation. 2008 Nov 15;86(9):1323-4. doi: 10.1097/TP.0b013e3181890788.

DOI:10.1097/TP.0b013e3181890788

PMID:19005418

Abstract

摘要

相似文献

What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?

Transplantation. 2008 Nov 15;86(9):1323-4. doi: 10.1097/TP.0b013e3181890788.

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis.

Liver Transpl. 2009 Aug;15(8):963-7. doi: 10.1002/lt.21769.

Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients.

Transplant Proc. 2007 Sep;39(7):2228-30. doi: 10.1016/j.transproceed.2007.07.039.

Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.

Biol Blood Marrow Transplant. 2009 Jun;15(6):730-40. doi: 10.1016/j.bbmt.2009.03.002. Epub 2009 Apr 11.

Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning.

Transplant Proc. 2004 Dec;36(10):3107-12. doi: 10.1016/j.transproceed.2004.11.092.

Selective low-dose valganciclovir for prevention of cytomegalovirus disease following kidney transplantation.

J Infect. 2008 Sep;57(3):236-40. doi: 10.1016/j.jinf.2008.06.016. Epub 2008 Jul 31.

Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease.

Transpl Infect Dis. 2004 Sep;6(3):101-9. doi: 10.1111/j.1399-3062.2004.00066.x.

Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation.

Clin Transplant. 2004 Aug;18(4):402-6. doi: 10.1111/j.1399-0012.2004.00180.x.

Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants.

Transplantation. 2007 Feb 15;83(3):290-6. doi: 10.1097/01.tp.0000251371.34968.ca.

Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation.

Clin Infect Dis. 2008 Mar 15;46(6):831-9. doi: 10.1086/528689.

引用本文的文献

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.

J Res Med Sci. 2014 Dec;19(12):1185-92.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验